An Observational Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in China
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Bortezomib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- Sponsors Xian-Janssen
- 06 Jun 2017 Status changed from not yet recruiting to recruiting.
- 14 Apr 2017 Planned initiation date changed from 22 Mar 2017 to 14 Apr 2017.
- 12 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 22 Mar 2017.